Earnings Call · Q2 FY2023·2023-08-04

Q2 23EPS -100.00%*·Rev n/aQ1 23EPS -36.67%·Rev n/aQ4 22EPS -55.56%·Rev n/aQ3 22EPS +44.23%·Rev n/a⚠ consensus missing

agilon health, inc. AGL

Matthew Gillmor — Vice President of Investor Relations

Steve Sell — CEO

Tim Bensley — CFO

+2.2%1d on move date+2.6% vs SPY3d+5.1%5d+0.3%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more AGL calls or request research access.

More AGL calls Browse calls Request research access